• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区发现对奥司他韦耐药的大流行(H1N1)2009 流感 A 病毒的早期结果。

Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.

机构信息

Centers for Disease Control, Taipei, Taiwan, ROC.

出版信息

Antiviral Res. 2010 Dec;88(3):256-62. doi: 10.1016/j.antiviral.2010.09.014. Epub 2010 Sep 24.

DOI:10.1016/j.antiviral.2010.09.014
PMID:20869989
Abstract

In this study, we investigated the frequency of oseltamivir resistance in pandemic (H1N1) 2009 influenza A viruses in Taiwan and characterized the resistant viruses. From May 2009 to January 2010, 1187 pandemic H1N1 virus-positive cases in Taiwan were tested for the H275Y substitution in the neuraminidase (NA) gene that confers resistance to oseltamivir. Among them, eight hospitalized cases were found to be infected with virus encoding the H275Y substitution in their original specimens collected after oseltamivir treatment. The epidemiologic investigation indicated that each of the cases occurred sporadically and there was no evidence of further transmission. We monitored the variation of amino acid residues at position 275 of the NA gene in a series of specimens taken at various time-points and observed that viruses encoding the H275Y substitution differ in their fitness in vivo and in MDCK cells. Phylogenetic analysis indicated that the hemagglutinin (HA) sequences of oseltamivir-resistant pandemic H1N1 viruses exhibited greater diversity than the NA sequences and progressive changes of the HA genes from clade A1 into A2 and from there into clade A3 were observed. The resistant viruses seemed to occur in combination with diverse HA genes and a dominant NA gene. Enzymatic analysis of the viruses revealed that the ratio of NA/HA activities in oseltamivir-resistant viruses was reduced considerably compared to those in wild-type ones.

摘要

在这项研究中,我们调查了台湾地区大流行(H1N1)2009 流感 A 病毒中奥司他韦耐药的频率,并对耐药病毒进行了特征分析。2009 年 5 月至 2010 年 1 月,我们对台湾地区 1187 例大流行 H1N1 病毒阳性病例进行了神经氨酸酶(NA)基因中 H275Y 取代检测,该取代赋予了对奥司他韦的耐药性。其中,在 8 例住院病例的原始样本中发现了奥司他韦治疗后编码 H275Y 取代的病毒。流行病学调查表明,每个病例都是散发的,没有进一步传播的证据。我们在一系列不同时间点采集的样本中监测了 NA 基因 275 位氨基酸残基的变异情况,观察到编码 H275Y 取代的病毒在体内和 MDCK 细胞中的适应性存在差异。系统进化分析表明,奥司他韦耐药性大流行 H1N1 病毒的血凝素(HA)序列比 NA 序列具有更大的多样性,并且观察到 HA 基因从 A1 进化分支逐渐变为 A2 和 A3 进化分支。耐药病毒似乎与多样化的 HA 基因和一个主要的 NA 基因同时出现。对病毒的酶分析表明,与野生型相比,奥司他韦耐药病毒的 NA/HA 活性比值大大降低。

相似文献

1
Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.台湾地区发现对奥司他韦耐药的大流行(H1N1)2009 流感 A 病毒的早期结果。
Antiviral Res. 2010 Dec;88(3):256-62. doi: 10.1016/j.antiviral.2010.09.014. Epub 2010 Sep 24.
2
Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.西班牙的耐奥司他韦的大流行性流感 A(H1N1)2009 病毒。
J Clin Virol. 2011 Jul;51(3):205-8. doi: 10.1016/j.jcv.2011.04.008. Epub 2011 May 17.
3
Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.2007 - 2008年呼吸道季节期间,加拿大安大略省多伦多出现的H275Y甲型流感病毒(H1N1)的基因微异质性
J Clin Virol. 2009 Jun;45(2):142-5. doi: 10.1016/j.jcv.2009.04.010. Epub 2009 May 17.
4
Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.2009-2011 年台湾地区奥司他韦耐药甲型 H1N1pdm09 流感病毒的特征。
J Med Virol. 2013 Mar;85(3):379-87. doi: 10.1002/jmv.23482. Epub 2012 Dec 21.
5
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.荷兰 2009-2010 年通过强化监测发现的奥司他韦耐药大流行 A(H1N1)2009 流感病毒。
Antiviral Res. 2011 Oct;92(1):81-9. doi: 10.1016/j.antiviral.2011.07.004. Epub 2011 Jul 13.
6
Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.日本 2008-2009 年季节性流感期间出现 H274Y 耐药的奥司他韦抗甲型 H1N1 流感病毒。
J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.
7
Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.检测与奥司他韦耐药相关的 H275Y 突变在严重大流行流感病毒 A/H1N1 09 感染中的快速出现。
Antiviral Res. 2010 Jul;87(1):16-21. doi: 10.1016/j.antiviral.2010.04.002. Epub 2010 Apr 10.
8
Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.德国流行的 A/H1N1 流感病毒的基因型和表型耐药性。
Antiviral Res. 2011 Jan;89(1):115-8. doi: 10.1016/j.antiviral.2010.11.001. Epub 2010 Nov 9.
9
Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.基因特征表明,2005 年至 2009 年期间,印度东部出现了对奥司他韦耐药的 H1N1 流感病毒。
Infect Genet Evol. 2010 Dec;10(8):1188-98. doi: 10.1016/j.meegid.2010.07.019. Epub 2010 Aug 1.
10
Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.分析美国 2009 年大流行期间临床怀疑感染奥司他韦耐药病毒的患者的流感病毒。
Antiviral Res. 2012 Mar;93(3):381-6. doi: 10.1016/j.antiviral.2012.01.006. Epub 2012 Feb 7.

引用本文的文献

1
Antiviral activity of phenanthrenes from the medicinal plant Bletilla striata against influenza A virus.药用植物白及中菲类化合物对甲型流感病毒的抗病毒活性
BMC Complement Altern Med. 2017 May 22;17(1):273. doi: 10.1186/s12906-017-1780-6.
2
Taiwan's Public Health National Laboratory System: Success in Influenza Diagnosis and Surveillance.台湾公共卫生国家实验室系统:在流感诊断与监测方面取得成功。 需要说明的是,台湾是中国的省级行政区,不存在“国家”一说,这种表述是不符合一个中国原则的错误说法。维护国家领土完整,人人有责。
Health Secur. 2017 Mar/Apr;15(2):154-164. doi: 10.1089/hs.2016.0104.
3
Prompt Oseltamivir Therapy Reduces Medical Care and Mortality for Patients With Influenza Infection: An Asian Population Cohort Study.
提示:奥司他韦治疗可降低流感感染患者的医疗护理需求和死亡率:一项亚洲人群队列研究。
Medicine (Baltimore). 2015 Jul;94(27):e1070. doi: 10.1097/MD.0000000000001070.
4
Antiviral activity of Ladania067, an extract from wild black currant leaves against influenza A virus in vitro and in vivo.野生黑加仑叶提取物 Ladania067 抗甲型流感病毒的体内外活性。
Front Microbiol. 2014 Apr 22;5:171. doi: 10.3389/fmicb.2014.00171. eCollection 2014.
5
Characterization of the anti-influenza activity of the Chinese herbal plant Paeonia lactiflora.中药芍药抗流感活性的表征
Viruses. 2014 Apr 23;6(4):1861-75. doi: 10.3390/v6041861.
6
Baicalein, Ethyl Acetate, and Chloroform Extracts of Scutellaria baicalensis Inhibit the Neuraminidase Activity of Pandemic 2009 H1N1 and Seasonal Influenza A Viruses.黄芩的乙酸乙酯和氯仿提取物抑制大流行性 2009 H1N1 和季节性流感 A 病毒的神经氨酸酶活性。
Evid Based Complement Alternat Med. 2013;2013:750803. doi: 10.1155/2013/750803. Epub 2013 Jun 20.
7
Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan.台湾 2009 年甲型 H1N1 流感大流行期间奥司他韦的使用和结果。
BMC Public Health. 2013 Jul 12;13:646. doi: 10.1186/1471-2458-13-646.
8
Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season.2011-12 年台湾流感流行以疫苗错配的乙型流感 Yamagata 系病毒为主的监测和疫苗效力。
PLoS One. 2013;8(3):e58222. doi: 10.1371/journal.pone.0058222. Epub 2013 Mar 5.
9
Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan.台湾大流行(2009-10)和大流行后(2010-11)期间的全国流感监测。
PLoS One. 2012;7(4):e36120. doi: 10.1371/journal.pone.0036120. Epub 2012 Apr 24.
10
Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus in Northern Greece.希腊北部出现对奥司他韦耐药的2009年甲型H1N1流感大流行病毒。
Hippokratia. 2011 Jul;15(3):272-4.